XUREPLI Trademark

Trademark Overview

On Wednesday, February 27, 2013, a trademark application was filed for XUREPLI with the United States Patent and Trademark Office. The USPTO has given the XUREPLI trademark a serial number of 85861326. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 5, 2017. This trademark is owned by Novartis AG. The XUREPLI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system and the genitourinary system; Pharmaceutical preparations for human use for the treatment of inflammatory disorders; Pharmaceutical preparations for human use for use in dermatology, hematology and oncology; Pharmaceutical preparations for human use for use in transplantation; Pharmaceutical preparations for human use for use in ophthalmology; Pharmaceutical preparations for human use for use in the gastroenterological areas and for the prevention and treatment of ocular disorders or diseases; Pharmaceutical preparations for human use, namely, anti-infectives; pharmaceutical preparations for treating bacterial-based diseases; Pharmaceutical preparations for human use, namely, antivirals, antibiotics and antifungals
xurepli

General Information

Serial Number85861326
Word MarkXUREPLI
Filing DateWednesday, February 27, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 5, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system and the genitourinary system; Pharmaceutical preparations for human use for the treatment of inflammatory disorders; Pharmaceutical preparations for human use for use in dermatology, hematology and oncology; Pharmaceutical preparations for human use for use in transplantation; Pharmaceutical preparations for human use for use in ophthalmology; Pharmaceutical preparations for human use for use in the gastroenterological areas and for the prevention and treatment of ocular disorders or diseases; Pharmaceutical preparations for human use, namely, anti-infectives; pharmaceutical preparations for treating bacterial-based diseases; Pharmaceutical preparations for human use, namely, antivirals, antibiotics and antifungals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 5, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, June 5, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 5, 2017ABANDONMENT - NO USE STATEMENT FILED
Friday, November 11, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 10, 2016EXTENSION 5 GRANTED
Saturday, October 29, 2016EXTENSION 5 FILED
Saturday, October 29, 2016TEAS EXTENSION RECEIVED
Thursday, June 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 1, 2016EXTENSION 4 GRANTED
Wednesday, April 27, 2016EXTENSION 4 FILED
Friday, May 27, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 27, 2016TEAS EXTENSION RECEIVED
Thursday, October 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 28, 2015EXTENSION 3 GRANTED
Monday, October 19, 2015EXTENSION 3 FILED
Tuesday, October 27, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 19, 2015TEAS EXTENSION RECEIVED
Tuesday, May 19, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 18, 2015EXTENSION 2 GRANTED
Thursday, April 16, 2015EXTENSION 2 FILED
Monday, May 18, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 16, 2015TEAS EXTENSION RECEIVED
Tuesday, October 28, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 24, 2014EXTENSION 1 GRANTED
Friday, October 24, 2014EXTENSION 1 FILED
Friday, October 24, 2014TEAS EXTENSION RECEIVED
Tuesday, April 29, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 4, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2014PUBLISHED FOR OPPOSITION
Wednesday, February 12, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 25, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, January 25, 2014ASSIGNED TO LIE
Thursday, January 2, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 9, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, December 8, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, December 8, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, June 16, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, June 16, 2013NON-FINAL ACTION E-MAILED
Sunday, June 16, 2013NON-FINAL ACTION WRITTEN
Tuesday, June 11, 2013ASSIGNED TO EXAMINER
Tuesday, March 5, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 2, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

xurepli pharmaceutical preparations human system disorders treatment prevention namely diseases anti